Pazopanib Enhances Paclitaxel-Induced Mitotic Catastrophe in Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) has perhaps the worst prognosis of any cancer, with a median survival of only about 5 months regardless of stage. Pazopanib monotherapy has promising clinical activity in differentiated thyroid cancers (generally attributed to vascular endothelial growth factor recept...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Isham, Crescent R., Bossou, Ayoko R., Negron, Vivian, Fisher, Kelly E., Kumar, Rakesh, Marlow, Laura, Lingle, Wilma L., Smallridge, Robert C., Sherman, Eric J., Suman, Vera J., Copland, John A., Bible, Keith C.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3905331/
https://ncbi.nlm.nih.gov/pubmed/23283368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.3004358
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items